MTCO3P27

Across TCGA pan-cancer cohorts, MTCO3P27 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCO3P27’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MTCO3P27 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCO3P27 is over-expressed in tumor.

THCA, PRAD, and LUSC are the cancer types where MTCO3P27 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCO3P27 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	+0.028	.033	2	view →
PRAD	All	All	+0.025	.042	2	view →
LUSC	All	All	+0.026	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTCO3P27–THCA

Open the THCA breakdown →